Journal · Infectious diseases · Updated 21 November 2026
Current Infectious Disease Reports
Read Current Infectious Disease Reports articles on DeepDyve. No university library needed.
Current Infectious Disease Reports publishes reviews on infectious disease, from new beta-lactamase inhibitor combinations and drug-resistant bacteria in transplant patients to animal-adapted tuberculosis, scrub typhus and apps that support antibiotic prescribing. Springer Nature publishes it. Current Infectious Disease Reports has published since 1999. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Current Infectious Disease Reports at a glance
- Full title
- Current Infectious Disease Reports
- Abbreviation (NLM)
- Curr Infect Dis Rep
- Publisher
- Springer Nature
- Print ISSN
- 1523-3847
- Online ISSN (eISSN)
- 1534-3146
- First published
- 1999
- Access model
- Hybrid (44% free to read in 2026)
Ways to access Current Infectious Disease Reports
44% of the articles Current Infectious Disease Reports published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 44% of Current Infectious Disease Reports articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Current Infectious Disease Reports. Check its journal list and whether it offers remote access.
- DeepDyve. Read Current Infectious Disease Reports articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Current Infectious Disease Reports’ 2025 Journal Impact Factor is 2.4, and its 5-year Impact Factor is 3.6.
2.4
Journal Impact Factor (2025)
3.6
5-year Impact Factor (2025)
3 days
Median time to first decision
Source: journal metrics on the Current Infectious Disease Reports homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Current Infectious Disease Reports research worth reading
Published January to November 2026. Summaries describe what the authors report.
-
Filling the Gaps: A Review and Update on Beta-Lactamase Inhibitor Combinations
The authors review the pharmacology, activity and clinical data for newly approved beta-lactam/beta-lactamase inhibitor combinations, including sulbactam/durlobactam, cefepime/enmetazobactam and aztreonam/avibactam, and pipeline agents aimed at drug-resistant gram-negative pathogens.
Jackson et al. · Current Infectious Disease Reports, published online January 24, 2026 · DOI 10.1007/s11908-025-00874-y
-
Multidrug Resistance Microorganism Colonization and Solid Organ Transplantation: The Current evidence
The authors review evidence that colonization with multidrug-resistant organisms raises the risk of infection after solid organ transplant, especially for lung and liver recipients, and argue it should not preclude transplantation, favoring a risk-adapted approach over routine decolonization.
Pascale et al. · Current Infectious Disease Reports, published online November 14, 2026 · DOI 10.1007/s11908-026-00891-5
-
Mobile Health Tools to Support Antimicrobial Prescribing: An Integrative Review of Digital Applications
In an integrative review of 15 studies, the authors report that mobile apps improved antibiotic prescribing habits, guideline adherence, knowledge and economic outcomes, but not clinical compliance or documentation, and that evidence on implementation strategies is limited.
Simon et al. · Current Infectious Disease Reports, published online May 22, 2026 · DOI 10.1007/s11908-026-00882-6
-
Animal-Adapted Tuberculosis Strains – a One-World Problem, a One Health Solution?
The authors review animal-adapted variants of the M. tuberculosis complex that can infect both people and animals, describe how genomic diagnostics have revealed organisms such as M. orygis, and call for coordinated One Health approaches.
Riopel et al. · Current Infectious Disease Reports, published online July 8, 2026 · DOI 10.1007/s11908-026-00887-1
-
Asymptomatic Scrub Typhus Infection in Humans: Current Understanding and the Knowledge Gaps
The authors review evidence on asymptomatic scrub typhus, noting that about 1 in 4 people in community surveys are seropositive without symptoms and that one South Indian cohort found 81.2 asymptomatic seroconversions per 1000 person-years versus 6.0 symptomatic cases.
Subbiah et al. · Current Infectious Disease Reports, published online August 6, 2026 · DOI 10.1007/s11908-026-00890-6
See every Current Infectious Disease Reports article on DeepDyve
Related journals
Questions about Current Infectious Disease Reports
How can I read Current Infectious Disease Reports articles without a subscription?
44% of Current Infectious Disease Reports articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Current Infectious Disease Reports articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Current Infectious Disease Reports?
Current Infectious Disease Reports’ NLM (PubMed) abbreviation is Curr Infect Dis Rep.
What is the ISSN of Current Infectious Disease Reports?
The print ISSN is 1523-3847 and the online ISSN is 1534-3146.
What is the impact factor of Current Infectious Disease Reports?
Current Infectious Disease Reports’ Journal Impact Factor is 2.4 (2025), and its 5-year Impact Factor is 3.6, according to Springer Nature’s published metrics.
Is Current Infectious Disease Reports open access?
Current Infectious Disease Reports is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 11 of 25 Current Infectious Disease Reports articles (44%) carry a Creative Commons license, per Crossref.
Current Infectious Disease Reports articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Current Infectious Disease Reports today
One month free, then less than $2 a day. Current Infectious Disease Reports, plus millions of articles from thousands of journals.




